Advanced Drainage Systems (WMS) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
5 Nov, 2026Executive summary
Q2 FY27 net sales rose 4.6% to $889.4M; Adjusted EBITDA was $286.8M, down 0.2% YoY, with a 32.2% margin versus 33.8%.
H1 net sales increased 12.5% to $1.891B, organic sales grew 2.3%, and Adjusted EBITDA rose 14.0% to $645.1M; the 34.1% margin was a record.
Challenged demand and a larger-than-expected Q1 pull-forward tempered results; innovation, material conversion, partnerships and acquisitions supported growth.
Financial highlights
Q2 continuing-operations net income fell 14.6% to $133.6M; diluted continuing-operations EPS declined 11.0% to $1.77.
H1 continuing-operations net income rose 3.2% to $310.2M; diluted continuing-operations EPS increased 5.0% to $4.02.
Q2 gross profit increased 1.7% to $345.9M; SG&A rose 8.7% to $129.6M, partly reflecting NDS and transaction costs.
H1 free cash flow was $359.5M versus $398.8M YoY; operating cash flow was $458.2M versus $509.8M, with working-capital changes driving the decline.
Outlook and guidance
FY27 net sales guidance was reduced to $3.300B–$3.400B; Adjusted EBITDA guidance is $1.000B–$1.030B, implying a ~30.3% margin.
Softer demand, higher rates, geopolitical uncertainty, lower-than-expected material inflation and reduced need for planned pricing actions informed the lower sales outlook; EBITDA guidance remained largely unchanged.
Estimated $40M–$50M of revenue shifted into Q1 from Q2, revised up from the prior $30M estimate.
FY27 capital expenditures are expected to be ~$200M, funded from operating cash flow; favorable price/cost is expected to offset unfavorable volume and transportation costs into H2.
Latest events from Advanced Drainage Systems
- Net sales and EBITDA surged on strong segment growth, NDS acquisition, and margin expansion.WMS
Q1 2027 - All proposals passed, including director elections and auditor ratification, with strong shareholder participation.WMS
AGM 2026 - Targeting >8% organic CAGR and >$1.2B EBITDA by FY30 through innovation and disciplined capital deployment.WMS
Investor Day 2026 - Strong financial results, performance-based executive pay, and enhanced ESG initiatives highlighted.WMS
Proxy filing - Votes will be held on directors, auditor ratification, and executive compensation.WMS
Proxy filing - Flat Q2 sales, resilient margins, profit down; FY25 outlook reflects Orenco acquisition, cost pressures.WMS
Q2 2025 - Q1 sales up 4.8% to $815M; margin strong at 33.8%, but net income down 6.7%.WMS
Q1 2025 - FY25 net sales up 1% to $2.90B, with margin pressure and cautious FY26 outlook.WMS
Q4 2025 - Net sales up 4.3% in Q3 FY25, but net income and margins declined amid higher costs.WMS
Q3 2025